ABT
Abbott Laboratories
101.30$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.4% | 48.7% | 49.6% | 48.9% | 49.0% | 49.0% | 47.4% | 43.6% | 44.3% | 43.0% | 43.7% | 42.0% | 43.2% | |
| 49.6% | 51.3% | 50.4% | 51.1% | 51.0% | 51.0% | 52.6% | 56.4% | 55.7% | 57.0% | 56.3% | 58.0% | 56.8% | |
| 6.5% | 6.7% | 6.9% | 6.7% | 6.7% | 6.6% | 6.8% | 6.6% | 6.9% | 6.4% | 6.8% | 7.0% | 6.8% | |
| 26.4% | 26.6% | 29.7% | 28.3% | 27.2% | 26.5% | 29.6% | 27.7% | 26.8% | 27.3% | 33.5% | – | – | |
| 33.1% | 33.1% | 36.5% | 34.9% | 33.9% | 32.9% | 36.3% | 38.0% | 37.9% | 37.4% | 39.8% | 43.8% | 39.8% | |
| 16.5% | 18.2% | 13.9% | 16.2% | 17.1% | 18.1% | 16.3% | 18.4% | 18.1% | 19.6% | 16.5% | 14.2% | 17.0% | |
| 1.5% | 2.3% | 1.2% | 1.6% | 1.6% | 1.4% | 1.3% | 1.1% | 0.4% | 1.0% | 1.6% | 2.4% | 1.4% | |
| 16.5% | 17.5% | 14.4% | 15.5% | 18.2% | 18.5% | 17.2% | 19.3% | 19.2% | 20.6% | 13.0% | 12.1% | 16.1% | |
| 2.3% | 2.0% | 2.1% | 2.9% | 2.8% | -65.6% | 4.4% | 3.3% | 4.7% | 5.1% | 3.3% | 4.7% | 4.5% | |
| 14.2% | 15.6% | 12.3% | 12.5% | 15.5% | 84.1% | 12.8% | 16.0% | 14.5% | 15.5% | 9.6% | 7.4% | 11.6% | |
| 26.1% | 27.8% | 23.7% | 24.9% | 27.3% | 27.2% | 25.8% | 27.4% | 27.2% | 24.6% | 20.1% | 14.2% | 21.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.